Biopatent Law: European vs. US Patent Law

  • Ulrich Storz
  • Martin Quodbach
  • Scott D. Marty
  • Derek E. Constantine
  • Matthew Parker
Part of the SpringerBriefs in Biotech Patents book series (BRIEFSBIOTECH)

Table of contents

  1. Front Matter
    Pages i-viii
  2. Martin Quodbach
    Pages 23-39
  3. Scott D. Marty, Derek E. Constantine, Matthew Parker
    Pages 41-66
  4. Back Matter
    Pages 67-69

About this book

Introduction

SpringerBriefs in Biotech Patents presents timely reports on intellectual properties (IP) issues and patent aspects in the field of biotechnology. This volume focus on particular aspects of the US patent law, which can have tremendous differences compared to the European law. This includes questions of biopatent prosecution, novelty, inventive step, written disclosure and sufficiency of enablement as well as questions of law enforcement of biotech patents.

Keywords

America Invents Act European Patent Convention Medical use claims Patent litigation Therapeutic compound patents

Authors and affiliations

  • Ulrich Storz
    • 1
  • Martin Quodbach
    • 2
  • Scott D. Marty
    • 3
  • Derek E. Constantine
    • 4
  • Matthew Parker
    • 5
  1. 1.Michalski Huettermann & Partner Patent AttorneysDuesseldorfGermany
  2. 2.Cornelius Bartenbach Haesemann and Partners (CBH)CologneGermany
  3. 3.Ballard Spahr LLPAtlantaUSA
  4. 4.Georgia State University AtlantaUSA
  5. 5.Maynard, Cooper & Gale, P.C.HuntsvilleUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-642-41293-6
  • Copyright Information The Author(s) 2014
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Biomedical and Life Sciences
  • Print ISBN 978-3-642-41292-9
  • Online ISBN 978-3-642-41293-6
  • Series Print ISSN 2192-9904
  • Series Online ISSN 2192-9912
  • About this book